Search results
Found 2893 matches for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
Emma Plested
Emma Plested - Programme and Regulatory Affairs Director (UK)
Daniel O'Connor
BSc AFHEA MSc DPhil (OXON) Daniel O'Connor - Associate Professor | Head of Bioinformatics
Yama G.Farooq
BCA Computer Application , MSc in Information Technology and Software Engineering Yama G.Farooq - Programming and Data Management Director
Stephane Paulus
MD, DTM&H, FRCPCH Stephane Paulus - Consultant in Paediatric Infectious Diseases
Sir Andrew Pollard
BSc MBBS PhD (Lond), DIC, MRCP (UK), FHEA, FRCPCH, MA, FMedSci, FRS Sir Andrew Pollard - Ashall Professor of Infection & Immunity